$Bio-Path Holdings(BPTH.US)$ NEWS Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
A Beacon of Hope: Bio-Path Holdings' Groundbreaking Progress in AML Treatment. In a significant stride toward combating refractory/relapsed acute myeloid leukemia (AML), Bio-Path Holdings, Inc. has recently announced the successful completion of the second dose cohort in the dose escalation portion of its Phase 1/1b clinical trial of BP1002. This marks a pivotal moment in the ongoing battle against one of...
Bio-Path Holdings股票讨论区
NEWS
Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
In a significant stride toward combating refractory/relapsed acute myeloid leukemia (AML), Bio-Path Holdings, Inc. has recently announced the successful completion of the second dose cohort in the dose escalation portion of its Phase 1/1b clinical trial of BP1002. This marks a pivotal moment in the ongoing battle against one of...
暂无评论